OBJECTIVE: There is a growing body of evidence on neurocognitive impairment in euthymic bipolar patients, but this issue has been studied mostly in bipolar I disorder, data on bipolar II (BD-II) are scant and discrepant. The two aims of this study were to ascertain whether strictly defined euthymic BD-II patients would present neurocognitive disturbances and to evaluate their impact on functional outcome. METHOD: Forty-three BD-II patients and 42 demographically and educationally matched healthy subjects were assessed with a comprehensive neuropsychological test battery and with the Social and Occupational Functioning Assessment Scale (SOFAS). The euthymia criteria were reduced (Hamilton Rating Scale for Depression score ≤6 and a Young Mania Rating Scale score ≤6) to minimize the influence of subdepressive symptomatology on cognition and functioning. RESULTS: BD-II patients showed a significantly lower performance on several measures of attention, learning and verbal memory, and executive function compared with healthy controls. The presence of subthreshold depressive symptomatology and one measure related to executive function (Trail Making Test, part B) was the variables that best predicted psychosocial functioning measured with the SOFAS. CONCLUSION: This report provides further evidence that euthymic BD-II patients present cognitive impairment which may impact psychosocial functioning.
OBJECTIVE: There is a growing body of evidence on neurocognitive impairment in euthymic bipolarpatients, but this issue has been studied mostly in bipolar I disorder, data on bipolar II (BD-II) are scant and discrepant. The two aims of this study were to ascertain whether strictly defined euthymic BD-II patients would present neurocognitive disturbances and to evaluate their impact on functional outcome. METHOD: Forty-three BD-II patients and 42 demographically and educationally matched healthy subjects were assessed with a comprehensive neuropsychological test battery and with the Social and Occupational Functioning Assessment Scale (SOFAS). The euthymia criteria were reduced (Hamilton Rating Scale for Depression score ≤6 and a Young Mania Rating Scale score ≤6) to minimize the influence of subdepressive symptomatology on cognition and functioning. RESULTS: BD-II patients showed a significantly lower performance on several measures of attention, learning and verbal memory, and executive function compared with healthy controls. The presence of subthreshold depressive symptomatology and one measure related to executive function (Trail Making Test, part B) was the variables that best predicted psychosocial functioning measured with the SOFAS. CONCLUSION: This report provides further evidence that euthymic BD-II patients present cognitive impairment which may impact psychosocial functioning.
Authors: Vicent Balanzá-Martínez; Benedicto Crespo-Facorro; Ana González-Pinto; Eduard Vieta Journal: Front Physiol Date: 2015-04-07 Impact factor: 4.566
Authors: Lisa O'Donnell; Joseph A Himle; Kelly Ryan; Andrew Grogan-Kaylor; Melvin G McInnis; Jenna Weintraub; Marisa Kelly; Patricia Deldin Journal: J Soc Social Work Res Date: 2017-07-19
Authors: Tae Hyon Ha; Ji Sun Kim; Jae Seung Chang; Sung Hee Oh; Ju Young Her; Hyun Sang Cho; Tae Sung Park; Soon Young Shin; Kyooseob Ha Journal: Psychiatry Investig Date: 2012-11-12 Impact factor: 2.505
Authors: Dzana Sudic Hukic; Louise Frisén; Lena Backlund; Catharina Lavebratt; Mikael Landén; Lil Träskman-Bendz; Gunnar Edman; Martin Schalling; Urban Ösby Journal: PLoS One Date: 2013-07-05 Impact factor: 3.240